Error 404 - Not Found

Suggestions

Vioxx's History and the Need for Procedural Changes and Better by M Gilhooley - 2007 - Cited by 19 - Related articles mit prompt action when the agency seeks warnings about a drug's risks found after marketing. to seek new warnings (including withdrawing a drug through an ad - become increasingly willing to defer to agency decisions to use in- .. post-approval clinical investigations to support any new use of a drug ,

FDA Warns on Painkillers; Drug Pulled - Los Angeles Times Thursday's action was one of the largest relabeling orders in FDA history. to withdraw the drug but had deferred to the wishes of regulators. A congressional investigation last year revealed that the FDA had February: An FDA panel concluded Vioxx , Celebrex and Bextra posed heart risks, advertisement

Q:\EVEN\ Vioxx \Orders & Reasons\ Vioxx .o&r.Preemption.final5.wpd File Format: PDF/Adobe Acrobat - Quick View On November 23, 1998, Merck submitted a new drug application for Vioxx to the Food . (A) full reports of investigations which have been made to show whether or not . that Congress does not cavalierly pre-empt state-law causes of action . . In the instant cases, Merck argues that the Court must defer to the

JAMA -- Postmarketing Surveillance--Lack of Vigilance, Lack of by PB Fontanarosa - 2004 - Cited by 146 - Related articles JAMA: The Journal Of the American Medical Association . . in the unpublished Adenomatous Polyp Prevention on Vioxx (APPROVe) study has . and products for which deferred pediatric studies are needed to establish safe use in children). 35 independent drug agency, and all data from these investigations as well

Health Beat: The AMA Would Make Health Care Unaffordable for Many Jun 11, 2009 Controversial drugs Vioxx and Avandia, which have subsequently been found to During a Senate investigation of abuses of the licensure

Drug and Device Law: Compounding, Repackaging, or Manufacturing? Jul 31, 2009 Over the years the FDA has deferred to state definitions of "compounding. The last bullet point - prohibiting all advertising , truthful or otherwise, was the kicker. . for the Office of Criminal Investigations -- a 17 year FDA veteran. Cross Jurisdictional Class Action Tolling Scorecard

Lack of Impact of Direct-to-Consumer Advertising on the Physician by B Parnes - 2009 - Cited by 7 - Related articles We know of only 1 previous investigation of patient requests for prescription Sparked in part by the withdrawal of Vioxx from the market in 2005, Congress , .. Time to ban direct-to-consumer prescription drug marketing. Provider deferred decisions on hemoglobin A1c results: a report from the Colorado

amednews: 2007 index by date American Medical News Dr. Pou's plight: Heroic actions , harrowing aftermath. AMA Leader Commentary: Autonomy vs. .. Commercial interruptions: The hidden costs of drug ads

C&EN Special Issue: Regulatory Trends Jun 19, 2006 Strong action on drug safety and pricing is more likely to come from states as blockbuster medicines, such as the arthritis drug Vioxx , . A number of states are considering proposals to ban direct-to-consumer advertising . . companies are paid to defer the marketing of particular drugs .

Drug Advertising Claims: Preemption's New Frontier File Format: PDF/Adobe Acrobat by CM Sharkey - Cited by 2 - Related articles drug advertising , taken up in Part III, hinges on an analysis of the .. Such calls were heightened in the wake of the Vioxx debacle, especially after the 2004 .. may submit complaints or requests for investigations to the. DDMAC.79 . regulation in the FDA, [the] Court should defer to the agency's